| Summary: | A number of novel 2,3,4,5-tetrahydro[1,3]diazepino[1,2-<i>a</i>]benzimidazole derivatives <b>2</b> were obtained by alkylation mainly in the 1<i>H</i>-tautomeric form of 2,3,4,5-tetrahydro[1,3]diazepino[1,2-<i>a</i>]benzimidazole or its 8,9-dimethyl-substituted analog 4-chlorobenzyl bromide, 4-chloroacetic acid fluoroanilide, and 4-tert-butylphenacyl bromide in neutral medium. Compounds 3 were cyclized and synthesized earlier with 11-phenacyl-substituted diazepino[1,2-<i>a</i>]benzimidazoles upon heating in conc. HBr. The chemical structures of the compounds were clarified by using the <sup>1</sup>H Nuclear Magnetic Resonance Spectroscopy (<sup>1</sup>H-NMR) technique. Anxiolytic properties were evaluated using the elevated plus maze (EPM) and open field (OF) tests. The analgesic effect of compounds was estimated with the tail flick (TF) and hot plate (HP) methods. Besides, possible the influence of the test compounds on motor activities of the animals was examined by the Grid, Wire, and Rotarod tests. Compounds <b>2d</b> and <b>3b</b> were the most active due to their prominent analgesic and anxiolytic potentials, respectively. The results of the performed in silico analysis showed that the high anxiolytic activity of compound <b>3b</b> is explained by the combination of a pronounced interaction mainly with the benzodiazepine site of the GABA<sub>A</sub> receptor with a prominent interaction with both the specific and allosteric sites of the 5-HT<sub>2A</sub> receptor.
|
|---|